| Literature DB >> 31080908 |
Bernadette P Marriott1, Travis H Turner2, Joseph R Hibbeln3, Marcie Pregulman4, Jill Newman4, Kristen B Johnson4, Angela M Malek5, Robert J Malcolm6, Gregory A Burbelo7, Jeffrey W Wissman8.
Abstract
Intake of nutrients fundamental for optimal neuronal function is of increasing interest. The potential importance of omega-3 highly unsaturated fatty acids (HUFAs) for optimizing emotional states, cognitive function, and mental health has been demonstrated in observational studies and randomized controlled trials. Omega-3 (HUFAs), specifically EPA (eicosapentaenoic acid) and docosahexaenoic acid (DHA), are concentrated in neural tissues and are essential for neural function, normative neurodevelopment, neurotransmitter, and neural immune functions. Omega-3 HUFAs must be obtained from the diet, predominantly from marine sources such as fish and other seafood. HUFAs also can be found in a variety of dietary supplements (omega-3 fatty acid esters, fish oil and krill oil). As dietary supplements, omega-3 HUFAs (fatty acid esters, fish and krill oils) differ substantially in their physicochemical properties and nutrient content. Here we present the design and methods for the Ranger Resilience and Improved Performance on Phospholipid bound Omega-3's (RRIPP-3) study. RRIPP-3 was a double blind, randomized, controlled trial among individuals in the United States (US) Army Infantry Basic Officer Leaders Course (IBOLC) and following US Ranger School training (RC) at Fort Benning, GA of omega-3 HUFA on krill oil versus placebo supplementation. The RRIPP-3 study sought to determine if krill oil supplementation with omega-3 HUFAs supports aspects of cognitive functioning critical to battlefield success when measured immediately after an intense combat simulation. Sub-analyses addressed basic improvements in IBOLC performance. We also describe additional outcome measures critical for interpretation of the study results, such as diet and other dietary supplement use.Entities:
Keywords: Cognition; Krill oil; Omega-3 fatty acids; Phospholipids; Resilience; US Army officers
Year: 2019 PMID: 31080908 PMCID: PMC6503132 DOI: 10.1016/j.conctc.2019.100359
Source DB: PubMed Journal: Contemp Clin Trials Commun ISSN: 2451-8654
RRIPP-3 study inclusion and exclusion criteria.
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| 1) Entry into IBOLC and planning on entering Ranger Course | 1) Infection, autoimmune disease, Coronary heart Disease, or fever of unknown origin |
| 2) No self-reported injuries that would impede potential physical performance success in IBOLC or Ranger Course | 2) History of non-febrile seizures |
| 3) Discontinue use of identified dietary supplements | 3) Known allergy to fish, crustaceans (shellfish) or nuts |
| 4) Agree to take 8 capsules a day (placebo or omega-3) | 4) Vegetarian food preference |
| 5) Regular use of omega-3 containing supplements of 5 g per day or more | |
| 6) Reported consumption of seafood three or more times per week within the last three months | |
| 7) Diagnosis of Type I or Type II diabetes | |
| 8) Take hypoglycemic agents | |
| 9) Refusal to stop taking specific dietary supplements pertinent to the study during participation | |
| 10) Refusal to avoid eating macadamia nuts | |
| 11) Intention to increase omega-3 consumption through diet | |
| 12) For women, pregnancy or intention to become pregnant during the potential study duration |
Fig. 1RRIPP-3 study flow.
Schedule of RRIPP-3 study visits and assessments.
| Domain | Instrument | Baseline | Safety Check | Pre-Leader Forge | Post-Leader Forge | Pre-Ranger | Post-Ranger |
|---|---|---|---|---|---|---|---|
| X | |||||||
| Demographics | |||||||
| HLQ | |||||||
| Height | |||||||
| Pregnancy test | |||||||
| X | X | X | X | X | X | ||
| Finger Prick - blood spot for fatty acid analysis | |||||||
| Weight | |||||||
| Adverse events | |||||||
| Pregnancy screen | |||||||
| X | X | ||||||
| Diet History Questionnaire (DHQ) Food Frequency Questionnaire– 30 day | |||||||
| Automated Multiple Pass Method (AMPM) 24-h dietary recalls | |||||||
| Supplement usage | |||||||
| X | X | X | X | ||||
| C-D RISC | |||||||
| STAI | |||||||
| POMS-Bi | |||||||
| PROMIS- Cognition | |||||||
| PROMIS- Fatigue | |||||||
| PROMIS- Sleep | |||||||
| X | X | X | X | ||||
| FCPAT | |||||||
| Stroop | |||||||
| Coding | |||||||
| Reasoning | |||||||
| Balloon Analogue Risk Task (BART) | |||||||
| 4 Choice RT | |||||||
| NPI | X | ||||||
| RSES | X | X | |||||
| PDI | X | ||||||
| 180 | 15 | 65 | 65 | 60 | 75 | ||